Welcome to the Metvix.com website

You are on the home page of Metvix.com - an online resource aimed at providing reliable and up-to-date information relating to Metvix® for Non-Melanoma Skin Cancer (NMSC) for Healthcare Professionals.

If you are not a Healthcare Professional please click here (by clicking on this link you will be leaving this site - Galderma is not responsible for the content).

Metvix® is a topical therapy for pre-cancerous and skin cancer lesions such as actinic keratoses, basal cell carcinomas and Bowen's disease.

Topical application of Metvix® results in the selective accumulation of photoactive molecules in the neoplastic tissue. Exposure to red light in the presence of oxygen generates reactive oxygen species which kill neoplastic cells. Healthy surrounding tissue is spared.

The links on this Homepage will lead you to useful resources relating to Metvix® for NMSC.

Sections include: About Metvix® - containing product information and practical treatment details; Clinical Resources; a Skin Cancer area outlining the epidemiology and diagnosis of NMSC; Patient Management - containing practical advice; What's New? and categorised Links. Additionally, there are numerous downloadable resources to aid you in your daily clinical practice as well as a Congress Calendar.

This site is for countries where Metvix is currently approved. If you require any further information please contact your local Galderma office by clicking here.

For press information click here.

Thank you for visiting Metvix.com.